Nicotinamide Market Size and Outlook 2031F

Global Nicotinamide Market: The Vitamin B3 Engine of Skin Health and Animal Nutrition

According to a TechSci Research report, The Global Nicotinamide Market is evolving from a standard vitamin ingredient segment into a strategic platform for pharmaceuticals, advanced skincare, and performance animal nutrition. Nicotinamide, the amide form of Vitamin B3, is a critical water‑soluble nutrient used in dermatology treatments, cosmeceutical formulations, and livestock feed additives that support metabolic health and disease prevention. Rising dermatological concerns, growth in preventive healthcare, and expansion of global feed production are anchoring demand, while shifting manufacturing models and new clinical applications broaden its strategic importance.

The Global Nicotinamide Market size stood at USD 717.21 Million in 2025 and is projected to reach USD 1063.13 Million by 2031 at a CAGR of 6.78%. Growth is driven by surging use in functional skincare and cosmeceuticals, robust expansion of the animal feed industry, and increasing pharmaceutical applications, even as geographic concentration of production and supply‑chain volatility create structural risk for downstream users.

Download Free Sample Report

➝ 𝐑𝐞𝐩𝐨𝐫𝐭 𝐃𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧

Forecast Period: 2027–2031
Market Size (2025): USD 717.21 Million
CAGR (2026–2031): 6.78%
Fastest Growing Segment: Pharmaceuticals
Largest Market: Asia Pacific
Market Size (2031): USD 1063.13 Million

➝ 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: 𝐖𝐡𝐲 𝐍𝐢𝐜𝐨𝐭𝐢𝐧𝐚𝐦𝐢𝐝𝐞 𝐌𝐚𝐭𝐭𝐞𝐫𝐬

What Nicotinamide Is and Where It’s Used

Nicotinamide (Niacinamide) is the amide form of Vitamin B3, a water‑soluble nutrient essential for cellular energy metabolism and skin barrier function.
It is widely used in pharmaceuticals for treating pellagra, dermatological conditions and vitamin deficiencies, and is increasingly studied for roles in diabetes and oncology.
Cosmetics and personal care rely on high‑purity nicotinamide as an active ingredient in serums and creams to improve barrier function, reduce hyperpigmentation, and support even skin tone.
Animal nutrition uses feed‑grade nicotinamide as a metabolic cofactor in poultry, swine and other livestock to improve growth, resilience and disease resistance.

Core Demand Pillars: Skin, Feed and Preventive Health

Rising skin barrier disorders and consumer interest in anti‑aging and brightening products make nicotinamide a cornerstone of modern dermocosmetics.
Global livestock and feed production growth pushes demand for Vitamin B3 as a critical feed additive, tightly linking nicotinamide consumption to meat and animal‑protein output.
Preventive healthcare trends drive higher intake of vitamin‑based dietary supplements, expanding nicotinamide’s role in OTC and nutraceutical formats.

➝ 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 & 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐓𝐫𝐞𝐧𝐝𝐬

Driver 1: Cosmeceutical and Anti‑Aging Skincare Demand

The boom in cosmeceuticals and anti‑aging skincare is a primary driver of nicotinamide demand.
Cosmetic brands are formulating serums, moisturisers and spot treatments with niacinamide to improve barrier function, reduce redness and address hyperpigmentation.
High consumer search interest—where niacinamide ranks among top skincare ingredients—pushes suppliers to scale cosmetic‑grade production with stringent purity specifications.

Driver 2: Expansion of Global Animal Feed and Livestock Production

Growth in global feed tonnage and livestock output is another strong driver.
Feed‑grade nicotinamide is essential for metabolic health and disease prevention in poultry and swine, supporting performance and food‑security objectives.
Expansion in animal nutrition businesses and rising demand for premixes directly translate into higher Vitamin B3 procurement across major feed producers.

Trend 1: Green Biomanufacturing and Low‑Carbon Production

Manufacturers are transitioning from traditional chemical synthesis to chemo‑enzymatic and microbial fermentation processes to reduce environmental impact.
Leading companies have committed to validated greenhouse‑gas reduction targets, positioning eco‑efficient nicotinamide production as a key differentiator for regulators and sustainability‑focused customers.
These biomanufacturing shifts align nicotinamide production with global climate goals and ESG requirements rather than just supply‑chain optimisation.

Trend 2: Growth in Male Grooming and Targeted Skincare

Nicotinamide use in male grooming is rising as men seek non‑greasy, barrier‑strengthening and tone‑evening skincare solutions.
Digital education and social‑media driven ingredient literacy have significantly increased searches for niacinamide serums among male users.
This demographic trend supports dedicated men’s products—serums, moisturisers and post‑shave treatments—featuring nicotinamide as a primary active.

The Global Nicotinamide Market grows from USD 717.21 Million (2025) to USD 1063.13 Million by 2031 at 6.78% CAGR. Explore drivers, trends, and biomanufacturing shifts.

➝ 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐡𝐚𝐥𝐥𝐞𝐍𝐆𝐄𝐒

Challenge 1: Geographic Concentration and Supply‑Chain Fragility

Manufacturing is heavily concentrated in limited regional hubs, creating a structurally fragile supply chain.
Strong reliance on specific production centres means regulatory changes or logistical disruptions in one country can ripple through global availability and pricing.
Import dependence—such as regions sourcing over 75% of Vitamin B3 from external suppliers—exposes pharma, feed and cosmetics industries to procurement risk.

Challenge 2: Price Volatility and Investment Risk

Concentrated export origins contribute to sharp price swings when capacity or trade flows change.
This volatility complicates long‑term planning for downstream users and can deter investment in new product lines that require stable nicotinamide supply.
Companies face friction in building resilient distribution networks and increasingly explore supplier diversification and alternative routes to mitigate risk.

➝ 𝐒𝐄𝐆𝐌𝐄𝐍𝐓𝐀𝐋 𝐈𝐍𝐒𝐈𝐆𝐇𝐓𝐒

Fastest‑Growing Segment: Pharmaceuticals

Pharmaceuticals are the fastest‑growing end‑use segment in the Global Nicotinamide Market.
Rising dermatological disorders, pellagra risks, and broader use of clinical‑grade Vitamin B3 in oral and topical therapies fuel growth.
Active research into nicotinamide’s role in managing diabetes, oncology and post‑viral syndromes, supported by regulatory validation of safety, expands its therapeutic reach.

Other Key End Uses

Cosmetics & Personal Care: High‑purity niacinamide for barrier repair, tone correction, anti‑aging and menopausal‑skin care.
Food & Beverages: Fortified foods and drinks, including infant nutrition and functional beverages, rely on nicotinamide as a micronutrient.
Animal Feed: Feed‑grade Vitamin B3 in poultry, swine and livestock premixes to support growth and health.
Chemicals: Intermediate and functional ingredient in specialty and industrial chemical applications.

➝ 𝐑𝐄𝐆𝐈𝐎𝐍𝐀𝐋 𝐈𝐍𝐒𝐈𝐆𝐇𝐓𝐒

Asia Pacific: Dominant Manufacturing and Consumption Hub

Asia Pacific leads the Global Nicotinamide Market as both a major manufacturing base and a fast‑growing demand centre.
Extensive production infrastructure in China and India offers cost‑effective Vitamin B3 supplies for global customers.
Strong personal‑care industries in South Korea and Japan, where nicotinamide is a staple in functional skincare, further reinforce the region’s leadership.

Other Regions: Europe, North America and Regulatory Focus

Europe and North America depend heavily on imported nicotinamide for feed, pharma and cosmetics, making supply resilience a key concern.
Local investments in cGMP facilities and new plants aim to reduce reliance on external suppliers and secure high‑purity grades.

➝ 𝐑𝐄𝐂𝐄𝐍𝐓 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓𝐒

A randomized controlled clinical trial on nicotinamide riboside (NR) supplementation showed improved NAD+ levels and better executive function, fatigue, depression and sleep in Long COVID patients, broadening the medical relevance of Vitamin B3 derivatives.
New in vivo skincare research demonstrated niacinamide’s efficacy in menopause‑related skin concerns, including reduced collagen degradation and increased ceramide levels, positioning it as a key active for post‑menopausal formulations.
Jubilant Ingrevia commissioned a 5,000‑tonne cGMP nicotinamide facility to supply nutraceuticals, food, infant nutrition and cosmetics with high‑grade Vitamin B3 and reduce exposure to feed‑grade market volatility.
Lonza’s strategic exit from certain nutrition‑ingredient businesses is reshaping the competitive landscape, concentrating its focus on CDMO activities and altering Vitamin B3 supply dynamics.

➝ 𝐂𝐎𝐌𝐏𝐄𝐓𝐈𝐓𝐈𝐕𝐄 𝐀𝐍𝐀𝐋𝐘𝐒𝐈𝐒

These companies focus on expanding nicotinamide capacity, improving purity and compliance for pharma and cosmetics, and strengthening positions in global feed and food markets.
Strategies include investing in USFDA‑aligned, cGMP facilities, targeting high‑margin segments like infant nutrition and cosmeceuticals, and diversifying export destinations.

➝ 𝐑𝐄𝐏𝐎𝐑𝐓 𝐒𝐂𝐎𝐏𝐄

Nicotinamide Market, By Sales Channel:

Direct
Indirect

Nicotinamide Market, By End Use:

Pharmaceuticals
Cosmetics & Personal Care
Food & Beverages
Animal Feed
Chemicals

Nicotinamide Market, By Region:

North America
Europe
Asia Pacific
South America
Middle East & Africa

➝ 𝐅𝐔𝐓𝐔𝐑𝐄 𝐎𝐔𝐓𝐋𝐎𝐎𝐊

The Global Nicotinamide Market is expected to grow steadily through 2031, supported by rising cosmeceutical demand, expanding animal feed production and new therapeutic applications. Green biomanufacturing and sustainability commitments will reshape production methods, while greater geographic diversification of manufacturing could mitigate current supply‑chain fragility. Companies that invest in eco‑efficient processes, high‑purity pharma and cosmetic grades, and robust distribution networks will be best positioned to capture value as Vitamin B3 moves deeper into preventive health, advanced skincare and specialised clinical nutrition.

Download Free Sample Report

➝ 𝐅𝐀𝐐𝐬: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐍𝐢𝐜𝐨𝐭𝐢𝐧𝐚𝐦𝐢𝐝𝐞 𝐌𝐀𝐑𝐊𝐄𝐓

What is nicotinamide and how is it different from niacin?
Nicotinamide (niacinamide) is the amide form of Vitamin B3 and provides similar nutritional benefits to niacin without the flushing side effect, making it more suitable for skincare and many supplements.

Why is the pharmaceuticals segment the fastest‑growing?
Increasing dermatological disorders, vitamin‑deficiency cases and expanding research into nicotinamide’s role in diabetes, oncology and post‑viral conditions drive rapid growth in clinical and therapeutic uses.

How important is nicotinamide in skincare?
It is a key active that strengthens the skin barrier, reduces hyperpigmentation, improves texture and supports hydration, making it central to anti‑aging, brightening and sensitive‑skin products.

What is the biggest structural risk facing the Nicotinamide Market?
Heavy geographic concentration of manufacturing and high import dependence create a fragile supply chain vulnerable to regulation, logistics disruptions and price volatility.

Why does Asia Pacific lead the Nicotinamide Market?
Asia Pacific combines large‑scale production facilities in China and India with strong demand from personal care, pharmaceuticals and nutrition, supported by regional regulatory frameworks that reinforce product safety and quality.